We are live on ! Find out more

7 hedge funds and large institutions have $867K invested in Daxor in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 3.52% → 3.52% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

13% less funds holding

Funds holding: 8 → 7 (-1)

16% less capital invested

Capital invested by funds: $1.03M → $867K (-$162K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$401

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.38K

DXR Hedge Fund Activity: Q2 2017 in Review

7 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q2 2017, worth a combined $867K — down 16% from $1.03M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DXR and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $401. The largest seller was Renaissance Technologies, cutting an estimated $1.38K.

  • 7 institutional investors held Daxor (DXR) as of Q2 2017, down from 8 in Q1 2017.
  • Funds reported $867K of Daxor stock for Q2 2017, down 16% quarter-over-quarter.
  • 0 funds opened new Daxor positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest Daxor buyer in Q2 2017 was Tower Research Capital (TRC), an estimated $401 added.
  • The largest Daxor seller in Q2 2017 was Renaissance Technologies, an estimated $1.38K sold.

Based on aggregated 13F filings for Q2 2017.